Cargando…

Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy

CONTEXT: WHO in its development of the roadmap on access to medicines and vaccines 2019–2023 has emphasized that the greatest challenge in achieving Universal Health Coverage (UHC) stem from persistent barriers to accessing health services and to accessing affordable and quality assured health produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Saravdekar, Suresh, Shukla, Vijay K., Upadhya, Omprakash P., Rai, Madhukar, Giri, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618235/
https://www.ncbi.nlm.nih.gov/pubmed/31334167
http://dx.doi.org/10.4103/jfmpc.jfmpc_287_19
_version_ 1783433874587516928
author Saravdekar, Suresh
Shukla, Vijay K.
Upadhya, Omprakash P.
Rai, Madhukar
Giri, Kiran
author_facet Saravdekar, Suresh
Shukla, Vijay K.
Upadhya, Omprakash P.
Rai, Madhukar
Giri, Kiran
author_sort Saravdekar, Suresh
collection PubMed
description CONTEXT: WHO in its development of the roadmap on access to medicines and vaccines 2019–2023 has emphasized that the greatest challenge in achieving Universal Health Coverage (UHC) stem from persistent barriers to accessing health services and to accessing affordable and quality assured health products. In this context, WHO introduced the concept of essential medicines in 1977, and since then, this concept, has been revised every 2 years and is accepted by many countries as guideline to develop National Drug Policy. The concept emphasizes that all aspects of drug management, including procurement, storage, distribution, and use, are easier if fewer essential medicines/items must be dealt with. Essential Medicines are those that satisfy the priority healthcare needs of the population. AIMS: During 2017-18, based on the principles of Essential Medicines Concept, we decided to develop and implement “Quality Procurement Management Policies’(QPMP) at Sir Sundar Lal Hospital, at Varanasi. The Pharmaco-econmics and Pharmacovigilance tools are also used to further maximize financial and therapeutic benefits. MATERIALS AND METHODS: This is evidence based, an observational, and retrospective study. Initially, the analysis of current data on sales of antibiotics during November 2017, December 2017, and January 2018, the procurement practices, selection of medicines, and pattern of use was studied and based on these findings reforms were designed and implemented through the Hospital Formulary Committee. RESULTS: This study revealed that- By the application of QPMP, both the Cost and Quality factors of Medication Management can be dealt with very effectively. And it is possible to make available Quality Assured Medicines at most economic prices, resulting in substantial savings. This study has further, shown that the confidence of physicians also improved as quality assured medicines are provided. CONCLUSION: The study at Sir Sundar Lal Hospital is thus worth emulating and shown that a doable roadmap with signposts at each and every turn can be designed and can be effectively implemented so that the goal of UHC can be achieved.
format Online
Article
Text
id pubmed-6618235
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66182352019-07-22 Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy Saravdekar, Suresh Shukla, Vijay K. Upadhya, Omprakash P. Rai, Madhukar Giri, Kiran J Family Med Prim Care Original Article CONTEXT: WHO in its development of the roadmap on access to medicines and vaccines 2019–2023 has emphasized that the greatest challenge in achieving Universal Health Coverage (UHC) stem from persistent barriers to accessing health services and to accessing affordable and quality assured health products. In this context, WHO introduced the concept of essential medicines in 1977, and since then, this concept, has been revised every 2 years and is accepted by many countries as guideline to develop National Drug Policy. The concept emphasizes that all aspects of drug management, including procurement, storage, distribution, and use, are easier if fewer essential medicines/items must be dealt with. Essential Medicines are those that satisfy the priority healthcare needs of the population. AIMS: During 2017-18, based on the principles of Essential Medicines Concept, we decided to develop and implement “Quality Procurement Management Policies’(QPMP) at Sir Sundar Lal Hospital, at Varanasi. The Pharmaco-econmics and Pharmacovigilance tools are also used to further maximize financial and therapeutic benefits. MATERIALS AND METHODS: This is evidence based, an observational, and retrospective study. Initially, the analysis of current data on sales of antibiotics during November 2017, December 2017, and January 2018, the procurement practices, selection of medicines, and pattern of use was studied and based on these findings reforms were designed and implemented through the Hospital Formulary Committee. RESULTS: This study revealed that- By the application of QPMP, both the Cost and Quality factors of Medication Management can be dealt with very effectively. And it is possible to make available Quality Assured Medicines at most economic prices, resulting in substantial savings. This study has further, shown that the confidence of physicians also improved as quality assured medicines are provided. CONCLUSION: The study at Sir Sundar Lal Hospital is thus worth emulating and shown that a doable roadmap with signposts at each and every turn can be designed and can be effectively implemented so that the goal of UHC can be achieved. Wolters Kluwer - Medknow 2019-06 /pmc/articles/PMC6618235/ /pubmed/31334167 http://dx.doi.org/10.4103/jfmpc.jfmpc_287_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Saravdekar, Suresh
Shukla, Vijay K.
Upadhya, Omprakash P.
Rai, Madhukar
Giri, Kiran
Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title_full Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title_fullStr Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title_full_unstemmed Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title_short Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
title_sort implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through who - essential medicine policy and adoption of nlem-based hospital formulary policy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618235/
https://www.ncbi.nlm.nih.gov/pubmed/31334167
http://dx.doi.org/10.4103/jfmpc.jfmpc_287_19
work_keys_str_mv AT saravdekarsuresh implementationofprinciplesofpharmacoeconomicsandpharmacovigilancetoachieveoptimalfinancialandtherapeuticbenefitsthroughwhoessentialmedicinepolicyandadoptionofnlembasedhospitalformularypolicy
AT shuklavijayk implementationofprinciplesofpharmacoeconomicsandpharmacovigilancetoachieveoptimalfinancialandtherapeuticbenefitsthroughwhoessentialmedicinepolicyandadoptionofnlembasedhospitalformularypolicy
AT upadhyaomprakashp implementationofprinciplesofpharmacoeconomicsandpharmacovigilancetoachieveoptimalfinancialandtherapeuticbenefitsthroughwhoessentialmedicinepolicyandadoptionofnlembasedhospitalformularypolicy
AT raimadhukar implementationofprinciplesofpharmacoeconomicsandpharmacovigilancetoachieveoptimalfinancialandtherapeuticbenefitsthroughwhoessentialmedicinepolicyandadoptionofnlembasedhospitalformularypolicy
AT girikiran implementationofprinciplesofpharmacoeconomicsandpharmacovigilancetoachieveoptimalfinancialandtherapeuticbenefitsthroughwhoessentialmedicinepolicyandadoptionofnlembasedhospitalformularypolicy